PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...

PET scans may serve as both a diagnostic and prognostic tool in giant cell arteritis (GCA), according to a new study. In over 100 patients with GCA who underwent 18 F-fluorodeoxyglucose (FDG) PET ...

At first glance, it might appear that better access to so-called amyloid-PET scans could compensate for some of the racial inequities in Alzheimer’s disease, as Linda Goler Blount called for in a ...

PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy. Treating patients with HER2-positive early breast cancer based on positron ...

(WNDU) - A PET scan is an imaging test that doctors traditionally use to evaluate patients for cancer, but it requires a dose of radiation, and a patient needs to lie still for 30 minutes or more. If ...

Mahajan Imaging & Labs has expanded its Alzheimer’s disease diagnostic services with the launch of an AI-integrated blood ...

Researchers say that a special digital imaging technique can spot the tau protein and predict cognitive decline in people with Alzheimer’s disease better than traditional imaging methods. Doctors ...

While PET scans have been used to predict Hodgkin lymphoma outcomes, adding Adcetris to frontline therapy improved outcomes for patients, regardless of their results. Adding Adcetris (brentuximab ...

A new PET scan reliably detects benign tumors in the pancreas, according to research led by Radboud university medical center. Current scans often fail to detect these insulinomas, even though they ...

WASHINGTON DC - JUNE 20, 2023 Jay Reinstein, who suffers from Alzheimer's, prepares to receive a PET scan at MedStar Georgetown University Hospital in Washington, DC. (Photo by Michael Robinson Chávez ...

Last year, the FDA gave accelerated approval of the antibody aducanumab (marketed as Aduhelm by Biogen) for the treatment of Alzheimer's disease. The approval was based solely on a presumed reduction ...